DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER).
Guidance for industry: diabetes mellitus – evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes.
2008 Verfügbar unter:
http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm071627.pdf
Access:
We do not assume any responsibility for the contents of the web pages of other providers.